{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:43Z","timestamp":1741238683343,"version":"3.38.0"},"reference-count":0,"publisher":"JLE","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.1684\/ejd.2022.4329","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:06:01Z","timestamp":1670245561000},"page":"645-646","source":"Crossref","is-referenced-by-count":3,"title":["Successful use of dalbavancin in the management of severe hidradenitis suppurativa"],"prefix":"10.1684","volume":"32","member":"18929","container-title":["European Journal of Dermatology"],"original-title":[],"link":[{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2022.4329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:27:09Z","timestamp":1741192029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2022.4329"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1684\/ejd.2022.4329","relation":{},"ISSN":["1167-1122"],"issn-type":[{"type":"print","value":"1167-1122"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}